InsidersTradesSigma
Explore the full record of transactions filed by Fitzgerald Thomas A, 首席财务官. Director active across 1 company, notably Transcode Therapeutics, Inc.. In total, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €14k. History available since 16 June 2022. The latest transaction was disclosed on 16 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Thomas A. Fitzgerald is the Chief Financial Officer of Transcode Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is crucial in ensuring the financial stability of Transcode Therapeutics and supporting its growth. With his expertise, he contributes to informed decision-making for the company's future.